These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 34187638)
1. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke. Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 34187638 [TBL] [Abstract][Full Text] [Related]
2. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke. Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 33858727 [TBL] [Abstract][Full Text] [Related]
3. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial. Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184 [TBL] [Abstract][Full Text] [Related]
4. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience. Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study. Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation. Noseworthy PA; Van Houten HK; Krumholz HM; Kent DM; Abraham NS; Graff-Radford J; Alkhouli M; Henk HJ; Shah ND; Gersh BJ; Friedman PA; Holmes DR; Yao X J Am Heart Assoc; 2022 Oct; 11(19):e027001. PubMed ID: 36172961 [TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation. Nielsen-Kudsk JE; Korsholm K; Damgaard D; Valentin JB; Diener HC; Camm AJ; Johnsen SP JACC Cardiovasc Interv; 2021 Jan; 14(1):69-78. PubMed ID: 33413867 [TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of Left Atrial Appendage Occlusion Versus Switch of Direct Oral Antcoagulant in Atrial Fibrillation: A Territory-Wide Retrospective Analysis. Ng AK; Ng PY; Ip A; Fung RC; Chui SF; Siu CW; Yan BP J Am Heart Assoc; 2023 Oct; 12(20):e029421. PubMed ID: 37804191 [TBL] [Abstract][Full Text] [Related]
9. Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk. Godino C; Melillo F; Bellini B; Mazzucca M; Pivato CA; Rubino F; Figini F; Mazzone P; Della Bella P; Margonato A; Colombo A; Montorfano M EuroIntervention; 2020 Apr; 15(17):1548-1554. PubMed ID: 31845892 [TBL] [Abstract][Full Text] [Related]
10. Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies. Li X; Wen SN; Li SN; Bai R; Liu N; Feng L; Ruan YF; Du X; Dong JZ; Ma CS Heart Rhythm; 2016 Jun; 13(6):1203-14. PubMed ID: 26724488 [TBL] [Abstract][Full Text] [Related]
11. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials. Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918 [TBL] [Abstract][Full Text] [Related]
13. Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial. Freixa X; Cruz-González I; Cepas-Guillén P; Millán X; Antúnez-Muiños P; Flores-Umanzor E; Asmarats L; Regueiro A; López-Tejero S; Li CP; Sanchis L; Rodés-Cabau J; Arzamendi D JAMA Cardiol; 2024 Oct; 9(10):922-926. PubMed ID: 39110427 [TBL] [Abstract][Full Text] [Related]
14. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence. Freixa X; Cruz-González I; Regueiro A; Nombela-Franco L; Estévez-Loureiro R; Ruiz-Salmerón R; Bethencourt A; Gutiérrez-García H; Fernández-Díaz JA; Moreno-Samos JC; Jiménez-Quevedo P; Martin-Yuste V; Arnold R; Millan X; Asmarats L; Ronquillo M; Agudelo-Montañez VH; López-Mínguez JR; Goicolea J; Pérez de Prado A; Arzamendi D J Invasive Cardiol; 2019 Aug; 31(8):212-216. PubMed ID: 31088992 [TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex. Zeitler EP; Kearing S; Coylewright M; Nair D; Hsu JC; Darden D; O'Malley AJ; Russo AM; Al-Khatib SM Circulation; 2023 Feb; 147(7):586-596. PubMed ID: 36780379 [TBL] [Abstract][Full Text] [Related]
16. Best anticoagulation strategy with and without appendage occlusion for stroke-prophylaxis in postablation atrial fibrillation patients with cardiac amyloidosis. Mohanty S; Torlapati PG; La Fazia VM; Kurt M; Gianni C; MacDonald B; Mayedo A; Allison J; Bassiouny M; Gallinghouse GJ; Burkhardt JD; Horton R; Di Biase L; Al-Ahmad A; Natale A J Cardiovasc Electrophysiol; 2024 Jul; 35(7):1422-1428. PubMed ID: 38751010 [TBL] [Abstract][Full Text] [Related]
17. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis. Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865 [TBL] [Abstract][Full Text] [Related]
18. Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study. Waranugraha Y; Lin LY; Tsai CT Trends Cardiovasc Med; 2024 May; 34(4):225-233. PubMed ID: 36775218 [TBL] [Abstract][Full Text] [Related]
19. Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs. apixaban (ADALA study). Flores-Umanzor EJ; Cepas-Guillen PL; Arzamendi D; Cruz-González I; Regueiro A; Freixa X J Interv Card Electrophysiol; 2020 Nov; 59(2):471-477. PubMed ID: 32986176 [TBL] [Abstract][Full Text] [Related]